Results 161 to 170 of about 5,602 (207)

Diffuse Large B-cell Lymphoma Complicated with Anti-3-hydroxy-3-methylglutaryl-Coenzyme A Reductase Immune-mediated Necrotizing Myopathy. [PDF]

open access: yesIntern Med
Tokunaga Y   +10 more
europepmc   +1 more source

Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge

Autoimmunity Reviews, 2022
This review is focused on the myopathological spectrum of immune mediated necrotizing myopathies (IMNMs) and its differentiation with other, potentially mimicking, inflammatory and non-inflammatory myopathies. IMNMs are a subgroup of idiopathic inflammatory myopathies (IIMs) characterized by severe clinical presentation with rapidly progressive ...
Merlonghi G., Antonini G., Garibaldi M.
openaire   +4 more sources

Immune-mediated necrotizing myopathy: clinical features and pathogenesis

Nature Reviews Rheumatology, 2020
Immune-mediated necrotizing myopathy (IMNM) is a group of inflammatory myopathies that was distinguished from polymyositis in 2004. Most IMNMs are associated with anti-signal recognition particle (anti-SRP) or anti-3-hydroxy-3-methylglutaryl-coA reductase (anti-HMGCR) myositis-specific autoantibodies, although ~20% of patients with IMNM remain ...
Allenbach, Yves   +3 more
openaire   +5 more sources

Immune-mediated necrotizing myopathy

Zeitschrift für Rheumatologie, 2016
Immune-mediated necrotizing myopathy (IMNM) is a newly identified subgroup of idiopathic inflammatory myopathies. It is defined as a rare and severe disease, with symmetrical and proximal muscle weakness and a characteristic histology. An autoimmune aspect of IMNM is suggested by its association with autoantibodies directed against signal recognition ...
C, Bergua   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy